3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and delivered strong market performance -- so strong that detractors might think it's too late to invest. Lilly's forward price-to-earnings (P/E) ratio currently tops 35, which is more than twice the average of 15.8 for the healthcare industry.And that's before we get into other issues, such as President Donald Trump's tariff policies, which could harm Lilly's financial results. Even with these potential headwinds, though, there are excellent reasons to invest in Eli Lilly. Let's consider three of them.Image source: Getty Images.Continue reading
Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and delivered strong market performance -- so strong that detractors might think it's too late to invest. Lilly's forward price-to-earnings (P/E) ratio currently tops 35, which is more than twice the average of 15.8 for the healthcare industry.
And that's before we get into other issues, such as President Donald Trump's tariff policies, which could harm Lilly's financial results. Even with these potential headwinds, though, there are excellent reasons to invest in Eli Lilly. Let's consider three of them.
Image source: Getty Images.
